Premium Information is available for this item - Upgrade for $1 a day
6505-01-189-3376
Usp Indomethacin Capsules
6505011893376 011893376 NDC00182-1682-05 NDC51285-0276-04 NDC00781-2350-05
INC: 33948 Indomethacin Capsules
May 2023
8
Marketplace 6505-01-189-3376
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-189-3376 5+ Documents (More...)
Usp Indomethacin Capsules 6505011893376 5427 Usp Indomethacin Capsules https 6505011893376 https
Usp Indomethacin Capsules 6505011893376 NSN Created on 14 Sep 1984 6505011893376 https// https/
Usp Indomethacin Capsules 6505011893376 6505-23-110-0052 6505-23-110-0052 6505-01-189-3376 https
6505010475426 Capsules 6505010475427NF XIV Managed by United https//www.nsnlookup.com Capsules 6505011893376
Usp Indomethacin Capsules 6505011893376 6505-01-189-3376 https//www.nsnlookup.com /fsg-65/fsc-6505
Primary Buy RNCC 3 RNVC 2 DAC 5 NATO Stock Numbers Related to 6505-23-110-0052 6505-23-110-0052 6505-01-189-3376
Usp Indomethacin Capsules 6505011893376 fsc-6505/us 6505- Capsules 6505011893376 https// https/
Capsules 65051900260971900260976505-19-002-6097 RQST NE Related Documents https Capsules https 6505011893376
Usp Indomethacin Capsules 6505011893376 9 Sep 1977 https https/ Sep 1984 6505011893376 https//www.nsnlookup.com
Usp Indomethacin Capsules 6505010475427 Managed by United States NSN Created on 9 Sep 1977 https 6505011893376
Restrictions 6505-01-189-3376
6505-01-189-3376 is a Usp Indomethacin Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-189-3376
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-189-3376
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-189-3376
- Part Number
- Manufacturer
- Status
- NDC00182-1682-05
- Manufacturer
- 63488 - Goldline Laboratories, Inc. (Active)
- Primary Buy
- Primary Buy
- NDC51285-0276-04
- 65974 - Duramed Pharmaceuticals, Inc (Active)
- Primary Buy
- Primary Buy
- NDC00781-2350-05
- 59043 - Geneva Pharmaceuticals Inc (Obsolete)
- Primary Buy
- Primary Buy
Datasheet 6505-01-189-3376
- Characteristic
- Specifications
- FIIG
- Specifications
- A510U0
- Capsule Type [AKJC]
- Any Acceptable
- Capsule Content Form [CQLS]
- Any Acceptable
- Active Medicament Medicinal Strength [AKJA]
- 50.000 Milligrams Indomethacin Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Capsule Primary Container Content Quantity [CYLZ]
- 500.000
Similar Supply Items to 6505-01-189-3376
Freight Information 6505-01-189-3376
6505-01-189-3376 has freight characteristics.. 6505-01-189-3376 has a variance between NMFC and UFC when transported by rail and the description should be consulted.